Sulprostone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(Z)-7-[(1R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
60325-46-4 |
| ATC code | G02AD05 (WHO) |
| PubChem | CID 5312153 |
| ChemSpider | 4471583 |
| UNII |
501Q5EQ1GM |
| KEGG |
D02725 |
| ChEMBL |
CHEMBL284178 |
| Chemical data | |
| Formula | C23H31NO7S |
| Molar mass | 465.56 g/mol |
| |
| |
| (verify) | |
Sulprostone is an oxytocic.
It is an analogue of prostaglandin E2.[1]
References
- ↑ Tamma G, Wiesner B, Furkert J, et al. (August 2003). "The prostaglandin E2 analogue sulprostone antagonizes vasopressin-induced antidiuresis through activation of Rho". Journal of Cell Science 116 (Pt 16): 3285–94. doi:10.1242/jcs.00640. PMID 12829746.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
